Anti-Vista Antibodies And Fragments

Patent No. EP3087098 (titled "Anti-Vista Antibodies And Fragments") was filed by Janssen Pharmaceutica on Dec 22, 2014. The application was issued on Apr 8, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
REGIMBEAUJan 9, 2021REGIMBEAU
MARGARET DIXONDec 10, 2020MEWBURN ELLIS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3087098

JANSSEN PHARMACEUTICA
Application Number
EP14833462A
Filing Date
Dec 22, 2014
Status
Revoked
Dec 3, 2021
Publication Date
Apr 8, 2020